Focus On the Impact of Chronic Constipation: A Managed Care Perspective
Including proceedings from a symposium held in Boston, Massachusetts
Activity Date: February 2007  — Activity Info: Volume4, (2)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

To provide pharmacists with up-to-date information about their role in the treatment of patients with chronic constipation.

This activity is designed for pharmacists. No prerequisites required.

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
  • Discuss the latest trends and issues important to managed care organizations as they relate to the diagnosis and treatment of chronic adult idiopathic constipation.
  • Review current concepts underlying the pathophysiology and management of chronic adult idiopathic constipation, including the impact of this disorder on the patient.
  • Evaluate new diagnostic and therapeutic strategies for chronic adult idiopathic constipation, in addition to their impact on healthcare utilization and patient care.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.

This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE Program #064-000-06-210-H01.

This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity:  2 hours.

Release date: February 15, 2007. Expiration date: February 15, 2009.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.

This program is supported by an educational grant from Sucampo Pharmaceuticals, Inc, and Takeda Pharmaceuticals North America, Inc.
Home | Contact Us | View Account | Need Help?